A detailed history of Ubs Group Ag transactions in Glaukos Corp stock. As of the latest transaction made, Ubs Group Ag holds 37,682 shares of GKOS stock, worth $4.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,682
Previous 37,115 1.53%
Holding current value
$4.5 Million
Previous $2.95 Million 20.44%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $43,318 - $54,619
567 Added 1.53%
37,682 $3.55 Million
Q4 2023

Feb 09, 2024

BUY
$59.53 - $85.11 $1.79 Million - $2.57 Million
30,144 Added 432.42%
37,115 $2.95 Million
Q3 2023

Nov 09, 2023

SELL
$69.23 - $79.09 $2.33 Million - $2.66 Million
-33,669 Reduced 82.85%
6,971 $524,000
Q2 2023

Aug 11, 2023

BUY
$45.44 - $71.21 $647,792 - $1.02 Million
14,256 Added 54.03%
40,640 $2.89 Million
Q1 2023

May 12, 2023

BUY
$43.88 - $52.48 $326,379 - $390,346
7,438 Added 39.26%
26,384 $1.32 Million
Q4 2022

Feb 08, 2023

BUY
$40.82 - $57.75 $433,141 - $612,785
10,611 Added 127.31%
18,946 $827,000
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $313,828 - $391,883
6,700 Added 409.79%
8,335 $444,000
Q2 2022

Aug 10, 2022

SELL
$34.86 - $63.77 $2,161 - $3,953
-62 Reduced 3.65%
1,635 $74,000
Q1 2022

May 16, 2022

SELL
$44.33 - $57.82 $534,265 - $696,846
-12,052 Reduced 87.66%
1,697 $98,000
Q4 2021

Feb 14, 2022

SELL
$40.27 - $56.99 $377,611 - $534,395
-9,377 Reduced 40.55%
13,749 $611,000
Q3 2021

Nov 15, 2021

BUY
$47.43 - $84.23 $951,018 - $1.69 Million
20,051 Added 652.07%
23,126 $1.12 Million
Q2 2021

Aug 13, 2021

SELL
$73.06 - $97.7 $1.31 Million - $1.75 Million
-17,917 Reduced 85.35%
3,075 $261,000
Q1 2021

May 12, 2021

BUY
$70.43 - $97.42 $873,261 - $1.21 Million
12,399 Added 144.29%
20,992 $1.76 Million
Q4 2020

Feb 11, 2021

BUY
$48.9 - $75.26 $343,473 - $528,626
7,024 Added 447.67%
8,593 $646,000
Q3 2020

Nov 12, 2020

BUY
$37.23 - $50.97 $3,127 - $4,281
84 Added 5.66%
1,569 $78,000
Q2 2020

Jul 31, 2020

SELL
$28.78 - $46.83 $360,670 - $586,873
-12,532 Reduced 89.41%
1,485 $57,000
Q1 2020

May 01, 2020

SELL
$25.53 - $70.14 $1.2 Million - $3.29 Million
-46,917 Reduced 77.0%
14,017 $433,000
Q4 2019

Feb 14, 2020

BUY
$54.18 - $65.64 $854,526 - $1.04 Million
15,772 Added 34.92%
60,934 $3.32 Million
Q3 2019

Nov 14, 2019

BUY
$58.58 - $83.91 $1.07 Million - $1.54 Million
18,298 Added 68.11%
45,162 $2.82 Million
Q2 2019

Aug 14, 2019

BUY
$63.59 - $78.71 $1.14 Million - $1.42 Million
17,999 Added 203.03%
26,864 $2.03 Million
Q1 2019

May 14, 2019

SELL
$50.75 - $80.54 $1.89 Million - $3.01 Million
-37,320 Reduced 80.81%
8,865 $695,000
Q4 2018

Feb 14, 2019

SELL
$52.18 - $67.93 $1.71 Million - $2.22 Million
-32,683 Reduced 41.44%
46,185 $2.59 Million
Q3 2018

Nov 14, 2018

BUY
$38.13 - $68.37 $401,318 - $719,594
10,525 Added 15.4%
78,868 $5.12 Million
Q2 2018

Aug 14, 2018

BUY
$27.62 - $44.51 $707,983 - $1.14 Million
25,633 Added 60.02%
68,343 $2.78 Million
Q1 2018

May 15, 2018

BUY
$26.05 - $34.5 $1.11 Million - $1.46 Million
42,424 Added 14833.57%
42,710 $1.32 Million
Q4 2017

Feb 14, 2018

SELL
$24.5 - $36.01 $28,689 - $42,167
-1,171 Reduced 80.37%
286 $7,000
Q3 2017

Nov 14, 2017

BUY
$31.26 - $42.03 $31,885 - $42,870
1,020 Added 233.41%
1,457 $48,000
Q2 2017

Aug 14, 2017

SELL
N/A
-11,118 Reduced 96.22%
437 $18,000
Q1 2017

Nov 14, 2017

BUY
N/A
11,555
11,555 $593,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $5.68B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.